Batemannt, Leach RM . ABC of Oxygen. BMJ1998; 317: 798-801

BIBLIOGRAFIA

BIBLIOGRAFIA

ATS Statement. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med1995; 152: S77-S120.

Back PN, Ghatei MA, Takashashi K. Formation of endothelin by cultured airway epithelial cells. FEBS Lett 1989; 255: 129-32.

Barberà JA, Peinado VI, Santos S. Pulmonary hypertension in COPD: old and new concepts. Monaldi Arch Chest Dis 2000; 55: 445-9.

BatemanNT, Leach RM. ABC of oxygen. BMJ1998; 317: 798-801.

Boysen PG, Block AJ, Wynne JW, Hunt LA, Flick MR. Nocturnal pulmonary hypertension in patients with chronic obstructive pulmonary disease. Chest 1979; 76: 536-542.

British Thoracic Society. Diagnosis and management of stable COPD. 1999.

British Thoracic Society. Clinical component for the home oxygen service in England and Wales.2006.

Bruna S, Onoscuri M. Ossigenoterapia a lungo termine domiciliare 1993; 1-52.

Coccagna G, Lugaresi E. Arterial blood gases and pulmonary and systemic arterial pressure during sleep in chronic obstructive pulmonary disease. Sleep 1978; 1: 117-124.

Connors Jr AF, Dawson NV, Thomas C, Harrell Jr FE, DesbiensN,Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus WA. Outcomes following acute exacerbation of severe COPD. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risk of Treatments).Am J Respir CritCare Med 1996; 154: 959-967.

Cooper CB. Long-term oxygen therapy. Principles and Practice ofPulmonary Rehabilitation 1993; 183-203.

COPD (Chronic, Obstructive Pulmonary Disease). Australian and New Zealand Management Guidelines and the COPD Handbook. 2002.

Crockett AJ, Cranston JM, Moss JR, Alpers JH. Survival on long-term oxygen therapy in chronic airflow limitation: from evidence to outcomes in the routine clinical setting. Intern Med J 2001; 31(8): 448-54.

De Marco R, Accordini S, Cerveri I, Corsico A, Sunyer J, Neukirch F, Kunzli N, Leynaert B, Janson C, Gislason T,Vermene P, SvanesC,Anto JM, Burney P. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax 2004; 59(2): 120-5.

Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847-52.

Dousset E, Decherchi P, Grelot L, Jammes Y. Effects of chronic hypoxemia on the afferent nerve activities from skeletal muscle. Am JCrit Care Med 2001; 164: 1476-80.

Dunne PJ. The demographics and economics of long-term oxygen therapy. Respir Care 2000; 45: 223-8.

Fabbri L, Romagnoli M, Cossi S, Grassi V.Broncopneumopatia cronica ostruttiva: una breve rassegna. Ann Ital Med Int 2003; 18: 219-230.

Farrero E, Escarrabill J, Prats E, Maderad M, Manresa F. Impact of hospital-based home-care program on the management of COPD patients receiving long-term oxygen therapy. Chest 2001; 119: 364-369.

Fauroux B, Sardet A, Foret D. Home treatment for chronic respiratory failure in children: a prospective study. Eur Respir J 1995; 8: 2062-2066.

Finkelstein R, Fraser RS, Ghezzo H, Cosio MG.Alveolar inflammation and ist relation to emphysema in smokers. Am J RespirCrit Care Med 1995; 152(1): 1666-72.

Flenley DC, Petty THL. Recent advances in respiratory medicine. 3rd ed. Edinburg: Churchill Livingstone, 1983: 173-91.

Fletcher EC, Luckett RA, Goodnight-White S, Miller CC, Qian W, Costarangos-Galarza C. A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mmHg. Am Rev Respir Dis 1992; 145: 1070-1076.

Fletcher EC, Luckett RA, Miller T, Costarangos C, Kutka N, Fletcher JG. Pulmonary vascular hemodynamics in chronic lung disease patients with and without oxyhemoglobin desaturation during sleep. Chest 1989; 95: 757764.

Fletcher EC, Miller J, Divine GW, Fletcher JG, Miller T. Nocturnal oxyhemoglobin desaturation in COPD patients with arterial oxygen tensions above 60 mmHg. Chest 1987; 92: 604-608.

Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645.

Foschino Barbaro MP, Serviddio G, Resta O, Rollo T, TamborraR,Elisiana Carpagnano G. Free Radic Res. 2005; 39 (10): 1111-8.

Garattini L, Cornago D. Ossigenoterapia a lungo termine: modalità di acquisto e distribuzione in Italia. Economia e Politica del Farmaco

2004; 2: 30.

Garattini L, Cornago D, Tediosi F. A comparative analysis of domiciliary oxygen therapy in five European countries. Health Policy2001; 58(2): 133-49.

Garattini L, Tediosi F. L’ossigenoterapia domiciliare in cinque paesi europei: un’analisi comparativa. Mecosan 2000; 35: 137-48.

Giaid A, Yanagisawa M, Langleben D. Expression of endothelin-l in the lungs of patients with pulmonary hypertension. N Engl J Med1993; 328: 1732-9.

GOLD (Global initiative for chronic Obstructive Lung Disease)Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Respir Care2001; 46(8): 798-825.

GOLD (Global initiative for chronic Obstructive Lung Disease)

Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2006 goldcopd.com

Grassi V, Cossi S, Tantucci C. Ossigenoterapia: I nuovi obiettivi. Dalla sopravvivenza alla qualità di vita correlata allo stato di salute. Ann Ital Med Int 2003; 18: 24-30.

Heaton RK, Grant I, McSweeny AJ, Adams KM, Petty TL. Psycological effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med1983; 143: 1941-1947.

Heindl S, Lehnert M, Criée CP, Hasenfuss G, Andreas S. Marked sympathetic activation in patients with chronic respiratory failure. AmJ Respir Crit Care Med 2001; 164: 597-601.

Hill AT, Bayley D, Stokley RA. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. Am J RespirCrit Care Med 1999; 160: 893-8.

HillemanDE, Dewan N, Maleskar M, Friedman M. Pharmacoeconomic Evaluation of COPD. Chest 2000; 118: 1278-85.

Hjalmarsen A, Waterloo K, Dahl A, Jorde R, Viitanem M. Effect of long term oxygen therapy on cognitive and neurological dysfunction in chronic obstructive pulmonary disease. Eur Neurol 1999; 42: 27-35.

Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 2000; 162: 701-6.

Jakobsson P, Jorfeldt L. Long term oxygen therapy may improve skeletal muscle metabolism in advanced chronic obstructive pulmonary disease patients with chronic hypoxemia. Respir Med1995; 89: 471-6.

Kaplan RM, Eakin EG, Ries AL. Psychosocial issues in the riabilitation of patients with chronic obstructive pulmonary disease. Principles and Practice of Pulmonary Rehabilitation 1993; 351-365.

Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alfa in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am JRespir Crit Care Med 1996; 153: 530-4.

Kidney J, McManus T, Coyle PV. Exacerbations of chronic obstructive pulmonary disease. Thorax 2002; 57: 753-754.

Levi-Valensi P, Aubry P, Rida Z, Rose D, Ndarurinze S, Jounieaux V. Selection of patients for long term O2 therapy. Eur Respir J 1989; 2(Suppl.): 624S-629S.

Linker ES, Karnick A, Lerner L. portable oxygen in chronic obstuctive lung disease with hypoxemia and cor pulmonale. A controlled double-blind crossover study. Chest 1975; 68: 236-41.

MacNee W. Prescrition of oxygen: still problems after all these years. American Journal of Respiratory and Critical Care Medicine2005; 172: 517-518.

Mak VH, Bugler JR, Roberts CM, Spiro SG. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation. Thorax 1993; 48(1): 33-38.

Mallory GB, Fullmer JJ, Vaughan DJ. Oxygen therapy for cystic fibrosis. Cochrane Database of systematic Reviews 2005; Issue 4.

Mantovani L. Quadro teorico di riferimento. L’intervento privato insanità 1995.

McElvaney NG, Crystal RG. Proteases and lung injury. The lung.Scientific Foundations 1997; 169: 2205-18.

Miravitlles M, Mayordomo C, Artés M, Sànchez-Agudo L,Nicolau F, Segù JL.Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. Respir Med 1999; 93: 173-9.

MRC (Medical Research Council). Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema: report of the Medical Research Council Working Party. Lancet 1981; 1: 681-6.

Mueller R, Chanez P, Campbell AM, Bonsquet J, Heusser C, Bullock GR. Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis. Respir Med 1996; 90: 79-85.

Mulloy E, McNicholas WT. Ventilation and gas exchange during sleep and exercise in severe COPD. Chest 1996; 109(2): 387-394.

Murgia A, Scano G, Palange P, Corrado A, Gigliotti F, Bellone A, Clini E, Ambrosino N. Linee Guida per la Ossigenoterapia a Lungo Termine (OTLT). Rassegna di patologia dell’apparato respiratorio2004; 19: 206-219.

Murray CJ, Lopez AD. Alternative projection of mortality by cause 1990-2020: global burden of disease study. Lancet 1997; 349: 1498-1504.

NICE (National Institute for Clinical Excellance). Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care.Thorax2004; 1: 1-232.

NOTT (Nocturnal Oxygen Therapy Trial Group). Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1981; 93: 391-8.

O’Donohue WJ. Effect of oxygen therapy on increasing arterial tension in hypoxemic patients with stable chronic obstructive pulmonary disease while breathing ambient air. Chest 1991; 100: 968-972.

Page CP, Banner KH, Spina D. Cellular mechanism in airways inflammation. Basel: Birkhauser Verlag, 2000.

Rees PJ, Dudley F. Oxygen therapy in chronic lung disease. BMJ1998; 317: 871-4.

Repine JE, Bast A, Laukhorst I. Oxidative stress in chronic obstuctive pulmonary disease. Am J Respir Crit Care Med 1997; 156: 341-57.

Saetta M, Di Stefano A, Turato G.CD8+ T lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 822-6.

Saetta M, Turato G, Baraldo S. Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir CritCare Med 2000; 161: 893-8.

Seemungal TAR, Donaldson GC, Bhowmik A, Jeffries DJ, WedzichaJA. Time course and recovery of exacerbations in patients with COPD. Am J Respir Crit Care Med 2000; 161: 1608-1613.

Selinger SR, Kennedy TP, Buescher P, Terry P, Parham W, Gofreed D, Medinger A, Spagnolo SV, Michael JR. Effects of removing oxygen from patients with chronic obstructive pulmonary disease. AmRev Respir Dis. 1987; 136: 85-91.

Silvestri G, Sherman C, Williams T. La cura del paziente terminale con cancro del polmone. Chest Edizione Italiana 2002; 4: 37.

Soriano JB, KiriVA, PrideNB, Vestbo J. Inhaled corticosteroids with/without long-acting beta-agonists reduce the risk of rehospedalization and death in COPD patients. Am J Respir Med2003; 2(1) :67-74.

Strom K. Long-term oxygen therapy: how can maximum benefit be achieved? Monaldi Arch Chest Dis 1997; 52: 249-252.

Sullivan SD, RamseySD, Lee TA. The economic burden of COPD. Chest 2000; 117(suppl 2): 5S-9S.

Swarski K, MacNee W, Wraith PK, Sliwinski P, Zielinski J. Predictors of survival in patients with chronic obstructive pulmonary disease treated with long-term oxygen therapy. Chest 1991; 100: 1522-1527.

Tarpy SP, Celli BR. Long term oxygen therapy. N Engl J Med 1995; 333: 710-4.

Thompson AB, Daughton D, Robbins RA, Ghafouri MA,Oehlerking M, Rennard SI. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis 1989; 140: 1527-37.

Tzanakis N. Oxygen therapy in chronic obstructive pulmonary disease. Eur Respir Mon 1998; 7: 169-179.

Veterans Health Administration. Clinical practice guideline for the management of chronic obstructive pulmonary disease.1999.

Viegi G, Pedreschi M, Baldacci S, Chiaffi L, Pistelli F, Modena P,Vellutini M, Di Pede F, Carrozzi L. Prevalence rates of respiratory symptoms and diseases in general population samples of North and Central Italy. Int J Tuberc Lung Dis 1999; 3(11): 1034-42.

Waterhouse JC, Howard P. Breathlessness and portable oxygen in chronic obstructive airways disease. Thorax 1983; 38: 302-306.

Weitzenblum E, Chaonat A, Kessler R, Schott R, Oswald M.Long-term oxygen therapy in stable COPD. Clinical management of chronic obstructive pulmonary disease. Lung volume in health and disease2002; 165: 781-812.

Weitzenblum E, Sautegau A, Ehrhart M, Mammosser M, Pellettier A. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Resp Dis 1985; 131: 493-498.

Zielinski J. Long-term oxygen therapy in conditions other than chronic obstructive pulmonary disease. Respir Care 2000; 45: 172-176.

Zielinski J, Bednarek M. Early detection of COPD in a high-risk population using spirometric screening. Chest 2001; 119(3): 731.

1